Olymvax Biopharmaceuticals(688319.SH)

Last Updated 00:00:00
longbridge loading

Olymvax Biopharmaceuticals: Shanghai Wushan has reduced its holdings by 3.00%

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals: Net profit in the third quarter was 34.2829 million yuan, a year-on-year increase of 7.22%

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

A-share innovative drug concept stocks fluctuated lower, with BETTA PHARMACEUTICALS falling over 10%, Jincheng Pharm, Konruns, Baillie Tianheng, Olymvax Biopharmaceuticals, and CCHT all dropping more than 5%

Zhitong·
SZ
300233
-2.28%
SZ
000661
-0.58%
SZ
300558
+1.74%
Zhitong·
SZ
300233
-2.28%
SZ
000661
-0.58%
SZ
300558
+1.74%

Chengdu Olymvax Biopharmaceuticals major shareholder reduces holdings, equity change reaches 1% threshold

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals plans to issue H shares and list on the Hong Kong Stock Exchange

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Two executives of Olymvax Biopharmaceuticals plan to reduce their shareholdings

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals plans to acquire a 15% stake in its controlling subsidiary, Xinnuoming Biotech

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals terminates the issuance of stocks to specific objects

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals: Announcement on the termination of the issuance of ordinary shares of RMB to specific objects through a simplified procedure and the withdrawal of application documents by Chengdu Olymvax Biopharmaceuticals Co., Ltd

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%

Olymvax Biopharmaceuticals released its semi-annual performance, with a net profit attributable to the parent company of 13.2 million yuan, turning a profit from a loss year-on-year

Zhitong·
SH
688319
-8.81%
Zhitong·
SH
688319
-8.81%
© 2026 Longbridge｜Disclaimer